vaccines

In a business driven by profit, vaccines have a problem. They’re not very profitable — at least not without government subsidies. Pharma companies favor…

Large populations of susceptible or at-risk people need to be studied in order to gauge the safety and efficacy of a coronavirus vaccine, says Dr. Richard Kennedy of the Mayo Clinic.

Florida, which has endured a surge of coronavirus infections this summer, will participate in a COVID-19 vaccine pilot program with the federal…

Russian President Vladimir Putin says that a coronavirus vaccine developed in his country has been cleared for use and one of his daughters has already…

Dr. Eric Coe jumped at the chance to help test a COVID-19 vaccine.At his urging, so did his girlfriend, his son and his daughter-in-law. All received…

The virus might eventually behave more like the common cold, according to Vineet Menachery, a coronavirus researcher at the University of Texas Medical Branch.

Moderna, one of the leading horses in the coronavirus vaccine race, has already made deals at between $32 and $37 a dose for some foreign countries. The U.S. price is expected to be lower.

Public health officials say a promising coronavirus vaccine is on its way in 2021. But does that matter if only half of Americans say they're willing to get such a vaccination?

Studies involving COVID-19 vaccine candidates in monkeys show promise of an effective vaccine, but it will take large-scale human trials to know for sure if they work.

The vaccine trial that Vice President Mike Pence kicked off in Miami on Monday gives the United States the tiniest chance of being ready to vaccinate…